Association between polymorphism within interleukin related genes and Graves' disease: a meta-analysis of 22 case-control studies
- PMID: 29228744
- PMCID: PMC5716784
- DOI: 10.18632/oncotarget.20114
Association between polymorphism within interleukin related genes and Graves' disease: a meta-analysis of 22 case-control studies
Abstract
Graves' disease (GD) is a common autoimmune disorder with a genetic predisposition. There is strong evidence to suggest that both Th1 and Th2 circulating cytokines are involved in the development of GD. In this study, we conducted a meta-analysis to assess the impact of seven variations of five IL-related genes on the susceptibility to GD. A total of 22 case-control studies involving 5338 GD patients and 6446 healthy controls were included. The results showed that only one SNP rs1800795 in IL-6 was significantly associated with GD in homozygous model (CC vs. GG: OR = 2.714, 95% CI = 1.047-7.039, p = 0.04), heterozygous model (CG vs. GG: OR = 1.295, 95% CI = 1.013-1.655, p = 0.039), dominant model (CC+CG vs. GG: OR = 1.418, 95% CI = 1.122-1.793, p = 0.003) and additive model (C vs. G: OR = 1.432, 95% CI = 1.087-1.886, p = 0.011).To explain the heterogeneity, we performed the subgroup analysis by ethnicity. The ethnicity stratification revealed that the association between rs1800795 and GD tended to be much stronger for Asian than European population in homozygous, dominant, recessive, and additive models. The remaining 6 SNPs in 4 genes did not show any significant association with GD in any genetic models. Together, our data support that rs1800795 within the IL-6 gene confers genetic susceptibility for GD. Future large-scale studies are required to validate the associations between IL-6 and others IL-related genes and GD.
Keywords: Graves’ disease; case/control study; interleukin; polymorphism; susceptibility.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest
Figures



Similar articles
-
Association of TNF-α promoter polymorphism and Graves' disease: an updated systematic review and meta-analysis.Biosci Rep. 2018 Mar 21;38(2):BSR20180143. doi: 10.1042/BSR20180143. Print 2018 Apr 27. Biosci Rep. 2018. PMID: 29440561 Free PMC article.
-
A comprehensive meta-analysis comprising 149 case-control studies to investigate the association between IL-6 gene rs1800795 polymorphism and multiple disease risk.Gene. 2023 Apr 20;861:147234. doi: 10.1016/j.gene.2023.147234. Epub 2023 Feb 1. Gene. 2023. PMID: 36736866
-
Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis.Front Neurol. 2022 Jan 6;12:799022. doi: 10.3389/fneur.2021.799022. eCollection 2021. Front Neurol. 2022. PMID: 35069427 Free PMC article.
-
Association between rs3087243 and rs231775 polymorphism within the cytotoxic T-lymphocyte antigen 4 gene and Graves' disease: a case/control study combined with meta-analyses.Oncotarget. 2017 Nov 27;8(66):110614-110624. doi: 10.18632/oncotarget.22702. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299173 Free PMC article.
-
Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.Thyroid. 2008 Nov;18(11):1201-6. doi: 10.1089/thy.2008.0098. Thyroid. 2008. PMID: 18925838 Free PMC article.
Cited by
-
IL-3: key orchestrator of inflammation.Front Immunol. 2024 Jun 13;15:1411047. doi: 10.3389/fimmu.2024.1411047. eCollection 2024. Front Immunol. 2024. PMID: 38938573 Free PMC article. Review.
-
Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid.Front Immunol. 2019 Mar 29;10:636. doi: 10.3389/fimmu.2019.00636. eCollection 2019. Front Immunol. 2019. PMID: 31001258 Free PMC article. Clinical Trial.
-
IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker.Front Immunol. 2022 Jan 24;13:824110. doi: 10.3389/fimmu.2022.824110. eCollection 2022. Front Immunol. 2022. PMID: 35140724 Free PMC article.
-
A data-driven approach for the discovery of biomarkers associated with thyroid eye disease.BMC Ophthalmol. 2021 Apr 9;21(1):166. doi: 10.1186/s12886-021-01903-9. BMC Ophthalmol. 2021. PMID: 33832456 Free PMC article.
-
IL-17 and IL-38 gene polymorphisms in thyroid-associated ophthalmopathy.Int Ophthalmol. 2024 Sep 18;44(1):379. doi: 10.1007/s10792-024-03317-0. Int Ophthalmol. 2024. PMID: 39292290
References
-
- Smith TJ, Hegedus L. Graves’ Disease. N Engl J Med. 2016;375:1552–1565. - PubMed
-
- McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42:252–265. - PubMed
-
- Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86:930–934. - PubMed
-
- Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536–539. - PubMed
-
- Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowden DW. Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. J Hum Genet. 2003;48:236–242. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources